Figure 2.
Incidence of ≥Gr3 NC AEs based on the characteristics of CRS. (A) Dot plot of ≥Gr3 NC AEs in patients based on the presence of CRS. (B) Dot plot of ≥Gr3 NC AEs in patients based on severity of CRS maximum grade 1 or 2 vs 3 or 4 as graded per American Society for Transplantation and Cellular Therapy guidelines. (C) Pie graph of ≥Gr3 NC AEs in patients with CRS based on the system. (D) Pie graph of ≥Gr3 NC AEs in patients without CRS based on the system. (E) Timing of ≥Gr3 NC AEs in patients with CRS separated based on the percentage, with onset before (before CRS, red) or after (after CRS, blue) the onset of CRS.

Incidence of ≥Gr3 NC AEs based on the characteristics of CRS. (A) Dot plot of ≥Gr3 NC AEs in patients based on the presence of CRS. (B) Dot plot of ≥Gr3 NC AEs in patients based on severity of CRS maximum grade 1 or 2 vs 3 or 4 as graded per American Society for Transplantation and Cellular Therapy guidelines. (C) Pie graph of ≥Gr3 NC AEs in patients with CRS based on the system. (D) Pie graph of ≥Gr3 NC AEs in patients without CRS based on the system. (E) Timing of ≥Gr3 NC AEs in patients with CRS separated based on the percentage, with onset before (before CRS, red) or after (after CRS, blue) the onset of CRS.

Close Modal

or Create an Account

Close Modal
Close Modal